You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 48 No. 11, November 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

The Bruns-Garland syndrome (diabetic amyotrophy). Revisited 100 years later

R. J. Barohn, Z. Sahenk, J. R. Warmolts and J. R. Mendell
Norman Allen Department of Neurology, Ohio State University Hospital, Columbus 43210-1228.

A group of 17 patients had proximal diabetic neuropathy characterized by abrupt onset of asymmetric pain and weakness. Fourteen patients had unilateral onset that later involved the other extremity in 3 days to 8 months. All patients reported stepwise or steady progression during 2 to 18 months that was documented during serial examinations. In 16 patients, both proximal and distal muscles were involved. Sural nerve biopsy specimens demonstrated multifocal variability in nerve fiber density manifesting as nonrandom fiber loss between and within fascicles compared with age-matched controls. These findings demonstrate that patients may have a rapidly evolving course of proximal diabetic neuropathy followed by continued progression for many months and emphasize the overlap between proximal diabetic neuropathies of presumed different types. Our cases and others cast doubt on notions supporting two distinct types of proximal diabetic neuropathies represented by the rapid evolution of asymmetric weakness on an ischemic basis, in contrast to a more slowly progressive condition of metabolic pathogenesis.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intravenous immunoglobulin therapy markedly ameliorates muscle weakness and severe pain in proximal diabetic neuropathy
Kawagashira et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:899-901.
ABSTRACT | FULL TEXT  

Nonsystemic vasculitic neuropathy: Insights from a clinical cohort
Collins et al.
Neurology 2003;61:623-630.
ABSTRACT | FULL TEXT  

Non-diabetic lumbosacral radiculoplexus neuropathy: Natural history, outcome and comparison with the diabetic variety
Dyck et al.
Brain 2001;124:1197-1207.
ABSTRACT | FULL TEXT  

Human immunoglobulin for diabetic amyotrophy{---}a promising prospect?
Courtney et al.
Postgrad. Med. J. 2001;77:326-328.
ABSTRACT | FULL TEXT  

Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy
Mendell et al.
Neurology 2001;56:445-449.
ABSTRACT | FULL TEXT  

Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy
Collins et al.
Neurology 2000;55:636-643.
ABSTRACT | FULL TEXT  

Progressive polyradiculoneuropathy in diabetes: correlation of variables and clinical outcome after immunotherapy
Jaradeh et al.
J. Neurol. Neurosurg. Psychiatry 1999;67:607-612.
ABSTRACT | FULL TEXT  

Proximal diabetic neuropathy presenting with respiratory weakness
Brannagan et al.
J. Neurol. Neurosurg. Psychiatry 1999;67:539-541.
ABSTRACT | FULL TEXT  

Diagnosis of Intermittent Vascular Claudication in a Patient With a Diagnosis of Sciatica
Gray
ptjournal 1999;79:582-590.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.